)
)
Neurocrine Biosciences Investor Relations Material
Latest events
Q4 2024
Neurocrine Biosciences
Access the full event backlog
Slides, Transcripts, and Reports from 12,000+ public companies
Latest reports from Neurocrine Biosciences Inc
Access all reports
Neurocrine Biosciences, Inc. is a specialty pharmaceutical company that has a pipeline of drugs targeting multiple diseases and disorders of the central nervous system (CNS), including movement disorders, endocrine disorders and psychiatry.
Key slides for Neurocrine Biosciences Inc
Q4 2024
Neurocrine Biosciences Inc
Q4 2024
Neurocrine Biosciences Inc
Latest articles
)
James Quincey: Coca-Cola Chairman and CEO
James Quincey has dedicated nearly three decades to The Coca-Cola Company, rising through the ranks to become CEO and Chairman of the company.
11 Mar 2025
)
PepsiCo: From Pepsi and Gatorade to Doritos and Lay's
PepsiCo has grown from a soda company into a global leader in food and beverages, with a portfolio of over 200 brands, including Pepsi, Lay's, and Gatorade.
11 Mar 2025
)
Bob Iger: Disney's Visionary CEO
Bob Iger is a legend in the entertainment industry, known for his visionary leadership and as one of the most influential CEOs in Disney's history.
10 Mar 2025
Ticker symbol
NBIX
Country
🇺🇸 United States